What is Square Pharmaceuticals Price-to-Operating-Cash-Flow?
As of today (2024-04-25), Square Pharmaceuticals's share price is BDT212.10.
Square Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT15.71. Hence, Square Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 13.50.
The historical rank and industry rank for Square Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:
DHA:SQURPHARMA'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.1 Med: 19.92 Max: 41.09
Current: 13.56
During the past 13 years, Square Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 41.09. The lowest was 12.10. And the median was 19.92.
Square Pharmaceuticals's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was BDT5.05.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT15.71.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Square Pharmaceuticals was 30.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -7.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.70% per year.
During the past 13 years, Square Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.70% per year. The lowest was -49.90% per year. And the median was 5.75% per year.
Square Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Square Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Square Pharmaceuticals Price-to-Operating-Cash-Flow Chart
|
Square Pharmaceuticals Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
16.83 |
13.53 |
17.40 |
14.92 |
21.76 |
|
Square Pharmaceuticals Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
17.46 |
18.05 |
21.76 |
15.85 |
13.38 |
Competitive Comparison of Square Pharmaceuticals's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Square Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Square Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Square Pharmaceuticals Price-to-Operating-Cash-Flow Calculation
Square Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 212.10 | / | 15.712 |
| = | 13.50 |
Square Pharmaceuticals's Share Price of today is BDT212.10.
Square Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT15.71.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Square Pharmaceuticals (DHA:SQURPHARMA) Business Description
Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.
Square Pharmaceuticals (DHA:SQURPHARMA) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:SQURPHARMA has been successfully added to your